The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors for patients with BRAFV600E-mutated metastatic non-small cell lung cancer: The FRONT-BRAF study.
 
Alessandro Di Federico
Honoraria - Society for Immunotherapy of Cancer
Consulting or Advisory Role - Hanson Wade; Novartis
 
Kaiwen Wang
No Relationships to Disclose
 
Monica Chen
Stock and Other Ownership Interests - docs; FIGS; Nordisk; Quest Diagnostics
Consulting or Advisory Role - Candel Therapeutics
Research Funding - ASCO; NIH
Travel, Accommodations, Expenses - AACR; ASCO
 
Adam Barsouk
No Relationships to Disclose
 
Arianna Pagliaro
No Relationships to Disclose
 
Lanyi Chen
No Relationships to Disclose
 
Francesca Ogliari
Speakers' Bureau - Amgen; Roche Italy; Sanofi
Travel, Accommodations, Expenses - Amgen; Johnson & Johnson
 
Paul Stockhammer
No Relationships to Disclose
 
Rajat Thawani
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Catalyst Pharmaceuticals; Johnson & Johnson/Janssen; Nuvation Bio; Pfizer
Travel, Accommodations, Expenses - Black Diamond Therapeutics
 
Shahm Raslan
Employment - Johns Hopkins Aramco Healthcare (I)
(OPTIONAL) Uncompensated Relationships - University of Miami
 
Eleonora Gariazzo
No Relationships to Disclose
 
Francesca Fusco
No Relationships to Disclose
 
Grace Hambelton
No Relationships to Disclose
 
Fabrizio Citarella
Speakers' Bureau - AstraZeneca; Novartis
 
David Meyer
No Relationships to Disclose
 
Marcelo Corassa
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb Brazil; Janssen; Lilly; MSD; Novartis; Pfizer; Sanofi/Regeneron; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Takeda
Travel, Accommodations, Expenses - MSD
 
Corey Langer
Honoraria - AstraZeneca; Genentech/Roche; Lilly/ImClone; Merck; Takeda Science Foundation
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Gilead Sciences; Lilly/ImClone; Merck; Novocure; Pfizer; Regeneron; Takeda
Research Funding - Advantagene (Inst); Amgen; Ariad (Inst); AstraZeneca; Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte; Inovio Pharmaceuticals (Inst); Johnson & Johnson/Janssen; Lilly; Merck (Inst); Stem CentRx (Inst); Trizell (Inst)
Other Relationship - Amgen; Lilly; OncoCyte; Peregrine Pharmaceuticals; Summit Therapeutics; Synta
 
Michael Offin
Honoraria - OncLive
Consulting or Advisory Role - American Society for Radiation Oncology; Jazz Pharmaceuticals; Novartis; Pfizer; PharmaMar; Targeted Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
(OPTIONAL) Uncompensated Relationships - Mesothelioma Applied Research Foundation
 
Marcelo Negrao
Consulting or Advisory Role - AstraZeneca; BMS; Genentech; Lilly; Pfizer; Sanofi
Speakers' Bureau - BIO Brasil; DAVA Oncology; IDEOlogy Health; Medscape; OncLive; Targeted Oncology
Research Funding - Alaunos Therapeutics (Inst); AstraZeneca (Inst); BMS (Inst); Genentech (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Navire (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - DAVA oncology; IDEOlogy Health; Targeted Oncology
Other Relationship - Apothecom; Ashfield Healthcare
 
Biagio Ricciuti
Honoraria - Targeted Oncology
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Guidepoint Inc; Regeneron